Related Experiment Videos
Lymphoma presenting as an intramuscular mass
1Department of Surgery, Chelsea and Westminster Hospital, London, UK.
The British Journal of Surgery
|February 4, 1998
Summary
Primary intramuscular non-Hodgkin's lymphoma has a good prognosis in patients. Early tissue diagnosis via needle core biopsy is crucial to avoid unnecessary surgeries for soft tissue tumors.
Area of Science:
- Oncology
- Pathology
Background:
- Intramuscular masses can be misdiagnosed, leading to unnecessary surgical interventions.
- Accurate diagnosis is essential for appropriate treatment of soft tissue tumors.
Purpose of the Study:
- To evaluate the prognosis of primary intramuscular non-Hodgkin's lymphoma.
- To highlight the importance of tissue diagnosis in managing intramuscular masses.
Main Methods:
- Retrospective analysis of 19 patients with undiagnosed soft tissue tumors over 4.5 years.
- Diagnosis confirmed as intramuscular non-Hodgkin's lymphoma.
- Treatment involved chemotherapy and/or radiotherapy for Stage IE disease.
Main Results:
- All 7 patients with Stage IE disease achieved complete remission after a mean follow-up of 43 months.
- Patients treated with chemotherapy or radiotherapy alone or in combination showed positive outcomes.
Conclusions:
- Primary intramuscular non-Hodgkin's lymphoma demonstrates a favorable prognosis.
- Needle core biopsy is vital for accurate tissue diagnosis, preventing overtreatment.